Navigation Links
Valeant Pharmaceuticals Announces Public Offering Of Common Shares
Date:6/17/2013

ements can generally be identified by the use of words such as "anticipate," "expect," "plan," "could," "may," "will," "should," "would," "intend," "seem," "potential," "appear," "continue," "future," believe," "estimate," "forecast," "project," variations of such words or other words that convey uncertainty of future events or outcome, although not all forward-looking statements contain these identifying words. Our forward-looking statements are subject to known and unknown risks and uncertainties, many of which are outside of our control and could cause actual results to differ materially and adversely from those expressed or implied by such statements. Those risks include, but are not limited to: our future economic performance, operating results, financial condition, capital resources or prospects; projections of revenue, expenses, income and losses, earnings (losses) per share, capital expenditures, dividends, growth rates or other financial items; market or industry trends, legal or regulatory developments; future events; the anticipated effect of acquisitions, litigation, new (or changes to existing) laws, regulations or accounting principles or other matters on our business, economic performance, operating results, financial condition, capital resources or prospects; our plans, objectives and strategies for future operations or otherwise; and our expectations and beliefs. Information concerning potential factors that could affect the Company's financial results is included in the Company's most recent annual or quarterly report and detailed from time to time in the Company's other filings with the Securities and Exchange Commission and the Canadian Securities Administrators. Readers are cautioned not to place undue reliance on any of these forward-looking statements. These forward-looking statements speak only as of the date hereof. The Company undertakes no obligation to update any of these forward-looking statements to reflect events or circumstances after
'/>"/>
SOURCE Valeant Pharmaceuticals International, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Valeant Pharmaceuticals Agrees To Acquire AcneFree And Certain Assets From University Medical
2. Valeant Pharmaceuticals Reports 2012 First Quarter Financial Results
3. Valeant Pharmaceuticals To Host Investor Day
4. Valeant Pharmaceuticals To Announce 2012 Second Quarter Results On August 2, 2012
5. Valeant Pharmaceuticals International, Inc. Agrees To Acquire Medicis Pharmaceutical Corporation For $44.00 Per Share In Cash
6. Valeant Pharmaceuticals To Present At UBS Annual Global Life Sciences Conference
7. Valeant Pharmaceuticals Announces Management Change
8. Valeant Pharmaceuticals To Syndicate Incremental Loans
9. Valeant Pharmaceuticals Appoints Howard Schiller To Board Of Directors
10. Valeant Pharmaceuticals Announces Launch of Concurrent Private Offerings of Senior Notes
11. Valeant Pharmaceuticals International, Inc. Announces Pricing Of Concurrent Private Offerings Of Senior Notes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2015)... , April 21, 2015 The non-invasive & minimally invasive cardiac output monitoring ... 2019. Geographically, Europe is segmented as Germany ... France and Rest of Europe (RoE). ... non-invasive & minimally invasive cardiac output monitoring devices market around 35.2% in 2014 followed ... Netherlands , Sweden , Poland ...
(Date:4/21/2015)... England , April 21, 2015 ... Queen,s Award for Enterprise, having more than doubled its ... Oxford PharmaGenesis today celebrates winning the Queen,s Award ... local employer is the world,s first HealthScience Communications consultancy, ... in areas of patient need. Having more than doubled ...
(Date:4/21/2015)... According to a new ... Cell, Blood, Gene Therapy), Product (Instruments, Services, Kits, ... Residual Contamination, Adventitious Agents) - Global Forecast to ... Testing Market was valued at $1,758.69 Million in ... a CAGR of 12.23% to reach $3,130.85 Million ...
Breaking Medicine Technology:European Non-invasive and Minimally Invasive Cardiac Output Monitoring Devices Market by Type, by End-User - Forecast to 2019 2European Non-invasive and Minimally Invasive Cardiac Output Monitoring Devices Market by Type, by End-User - Forecast to 2019 3Queen's Award Crowns Achievements of Local Consultancy 2Queen's Award Crowns Achievements of Local Consultancy 3Queen's Award Crowns Achievements of Local Consultancy 4Queen's Award Crowns Achievements of Local Consultancy 5Biologics Safety Testing Market Worth $3,130.85 Million by 2019 2Biologics Safety Testing Market Worth $3,130.85 Million by 2019 3Biologics Safety Testing Market Worth $3,130.85 Million by 2019 4
... YORK, Dec. 15, 2011  New York University and the ... they have appointed Theodore (Ted) Rappaport, 51, to lead ... Rappaport, currently the William and Bettye ... at Austin (UTA), is a leading educator and entrepreneur ...
... 15, 2011  Today, the Consumer Healthcare Products Association (CHPA), announced ... Five Moms campaign to raise awareness of ... of two teenage boys and a high school math teacher ... the dangers of substance abuse. Millions of ...
Cached Medicine Technology:Wireless Engineering Pioneer Joins NYU-Poly and NYU 2Wireless Engineering Pioneer Joins NYU-Poly and NYU 3Wireless Engineering Pioneer Joins NYU-Poly and NYU 4CHPA's Five Moms Campaign to Stop Medicine Abuse Welcomes New Mom Tammy Walsh 2CHPA's Five Moms Campaign to Stop Medicine Abuse Welcomes New Mom Tammy Walsh 3
(Date:4/21/2015)... California (PRWEB) April 21, 2015 On ... Movie Awards” EcoLuxe Lounge at the world famous Avalon ... of sustainable product placement in TV and film, the ... makes appearances at many awards ceremonies and festivals throughout ... top providers of eco-friendly and socially conscious products and ...
(Date:4/21/2015)... Texas (PRWEB) April 21, 2015 ... Sodium Citrate Industry is a professional and in-depth ... Sodium Citrate Market with a focus ... included in the sodium citrate market research are ... Chemicals, Natural Biological, Cofco Biochemical, Capchem, Lianyungang Mupro ...
(Date:4/21/2015)... PA (PRWEB) April 21, 2015 This ... & Related Skin Types, Inc.® (FIRST) will publish a ... The campaign will run throughout the month of May ... It Matters to Someone." The positioning was chosen ... this rare skin disorder and to help support our ...
(Date:4/21/2015)... Further strengthening ties between the two ... donated goods and services to the University of South ... Health BRIDGE Healthcare Clinic. , The BRIDGE clinic – ... eighth year – provides primary medical care to more ... week inside the USF Health Morsani Center for Advanced ...
(Date:4/21/2015)... 21, 2015 Approximately 75 million Americans ... U.S. Environmental Protection Agency (EPA). On top of this, ... smoke increase the level of toxins found in the ... these harmful toxins is to increase consumption of broccoli. ... highest level of glucoraphanin – a long-lasting antioxidant – ...
Breaking Medicine News(10 mins):Health News:Hollywood's Santana Dempsey and Choices Recovery South Bend Examine Victory over Personal Struggles 2Health News:Sodium Citrate Industry Global Key Manufacturers Analysis Report 2015-2020 2Health News:Sodium Citrate Industry Global Key Manufacturers Analysis Report 2015-2020 3Health News:May is Ichthyosis Awareness Month. Use Your Voice. 2Health News:USF Health and Florida Hospital Tampa Partner to Expand BRIDGE Clinic 2Health News:USF Health and Florida Hospital Tampa Partner to Expand BRIDGE Clinic 3Health News:New Survey Shows Americans Are Cooking the Health Out of Broccoli 2Health News:New Survey Shows Americans Are Cooking the Health Out of Broccoli 3
... ... Healthcare, OAKLAND, Calif., May 1 With talk of a ... poll,this week illustrates that Californians will once again pay particular,attention to ... poll this week by the influential Field Institute released documented,that CNA ...
... of high blood pressure-related deaths occur in poorer ... -- Roughly 80 percent of high blood pressure-related deaths ... study by New Zealand researchers shows. , Once regarded ... pressure is now a global problem that affects both ...
... London, New Delhi, and Singapore (May 2, 2008) SAGE, ... Journal of School Nursing (JOSN) and the NASN Newsletter ... in August 2008., JOSN provides a forum for advancing ... of school nurses, and improving the health of children ...
... AMRIX Growing Rapidly ... Successfully Launched in April, FRAZER, Pa., May 1 ... $433.9 million, compared,to sales of $423.9 million for the first ... million. Basic income per common share for,the quarter was $0.57. ...
... battling illnesses more likely to make up lost slumber ... Older adults with sleep problems, pain, diabetes and respiratory ... day, a U.S. study finds. , Researchers from Vanderbilt ... people, average age 80.1 years, who were monitored for ...
... medical centers in the United States, Canada, Sweden, ... transplanting clusters of insulin-producing islets in adults with ... funded by the National Institutes of Health (NIH), ... islet transplantation lead to improved, long-lasting control of ...
Cached Medicine News:Health News:Field Poll: California Nurses Association Most Favorably Viewed Group in Healthcare Arena 2Health News:Field Poll: California Nurses Association Most Favorably Viewed Group in Healthcare Arena 3Health News:Hypertension Takes Huge Toll in Developing Countries 2Health News:The National Association of School Nurses selects SAGE to publish its journal 2Health News:Cephalon Reports Strong First Quarter Earnings 2Health News:Cephalon Reports Strong First Quarter Earnings 3Health News:Cephalon Reports Strong First Quarter Earnings 4Health News:Cephalon Reports Strong First Quarter Earnings 5Health News:Cephalon Reports Strong First Quarter Earnings 6Health News:Cephalon Reports Strong First Quarter Earnings 7Health News:Cephalon Reports Strong First Quarter Earnings 8Health News:Cephalon Reports Strong First Quarter Earnings 9Health News:Cephalon Reports Strong First Quarter Earnings 10Health News:Cephalon Reports Strong First Quarter Earnings 11Health News:Cephalon Reports Strong First Quarter Earnings 12Health News:Napping Habits Tied to Sleep Disorders 2Health News:Studies test new approaches to islet transplantation 2Health News:Studies test new approaches to islet transplantation 3Health News:Studies test new approaches to islet transplantation 4
Used for drainage and retrograde pyelogram in pediatric patients. A stiffening stylet is included to aid in catheter placement. Supplied sterile in peel-open packages. Intended for one-time use....
... temporary internal drainage from the ... Supplied sterile in peel-open packages. ... Periodic evaluation is advised; polyurethane, ... not remain indwelling more than ...
... Used for urethral stenting ... drainage following hypospadias repair. ... to be stabilized in ... of sutures at the ...
... temporary internal drainage from ... the bladder. Supplied sterile ... for one-time use. CAUTION: ... C-Flex® and Sof-Flex® stents ...
Medicine Products: